A Director at Arena Pharma is Exercising Options


Today it was reported that a Director at Arena Pharma (ARNA), Tina Susan Nova, exercised options to sell 1,200 ARNA shares at $40.10 a share, for a total transaction value of $55.18K. The options were close to expired and Tina Susan Nova disposed stocks.

See today’s analyst top recommended stocks >>

Currently, Arena Pharma has an average volume of 403K.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts